-
Je něco špatně v tomto záznamu ?
Association of FcRn expression with lung abnormalities and IVIG catabolism in patients with common variable immunodeficiency
T. Freiberger, L. Grodecká, B. Ravcuková, B. Kurecová, V. Postránecká, J. Vlcek, J. Jarkovský, V. Thon, J. Litzman,
Jazyk angličtina Země Spojené státy americké
Typ dokumentu časopisecké články, práce podpořená grantem
Grantová podpora
NR9192
MZ0
CEP - Centrální evidence projektů
- MeSH
- běžná variabilní imunodeficience genetika imunologie patologie patofyziologie MeSH
- dospělí MeSH
- exprese genu MeSH
- fenotyp MeSH
- imunoglobulin G krev MeSH
- intravenózní imunoglobuliny krev MeSH
- lidé středního věku MeSH
- lidé MeSH
- messenger RNA genetika metabolismus MeSH
- MHC antigeny I. třídy genetika MeSH
- minisatelitní repetice MeSH
- mladiství MeSH
- mladý dospělý MeSH
- plíce imunologie patologie patofyziologie MeSH
- promotorové oblasti (genetika) MeSH
- receptory Fc genetika MeSH
- senioři MeSH
- Check Tag
- dospělí MeSH
- lidé středního věku MeSH
- lidé MeSH
- mladiství MeSH
- mladý dospělý MeSH
- mužské pohlaví MeSH
- senioři MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
The neonatal Fc receptor (FcRn) acts as a key regulator of IgG homeostasis and is an important sensor of luminal infection. We analyzed the influence of FcRn expression on disease phenotype and the catabolism of therapeutically administered intravenous immunoglobulins (IVIG) in 28 patients with common variable immunodeficiency (CVID). Patients with generalized bronchiectasis and fibrosis had lower levels of FCRN mRNA compared to patients without these complications (P=0.027 and P=0.041, respectively). Moreover, FCRN mRNA levels correlated negatively with the extent of bronchiectasis and the rate of IgG decline after infusion of IVIG (P=0.027 and P=0.045, respectively). No relationship of FCRN expression with age at disease onset, age at diagnosis, diagnostic delay, IgG levels or frequency of infections before or during replacement immunoglobulin treatment, the presence of lung functional abnormalities, chronic diarrhea, granulomas, lymphadenopathy, splenomegaly or autoimmune phenomena was observed. Our results showed that FcRn might play a role in the development of lung structural abnormalities and in the catabolism of IVIG in patients with CVID.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc12025618
- 003
- CZ-PrNML
- 005
- 20130508102538.0
- 007
- ta
- 008
- 120817s2010 xxu f 000 0#eng||
- 009
- AR
- 024 7_
- $a 10.1016/j.clim.2010.05.006 $2 doi
- 035 __
- $a (PubMed)20627700
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Freiberger, Tomáš $7 xx0071641 $u Molecular Genetics Laboratory, Centre for Cardiovascular Surgery and Transplantation, Brno, Czech Republic. tomas.freiberger@cktch.cz
- 245 10
- $a Association of FcRn expression with lung abnormalities and IVIG catabolism in patients with common variable immunodeficiency / $c T. Freiberger, L. Grodecká, B. Ravcuková, B. Kurecová, V. Postránecká, J. Vlcek, J. Jarkovský, V. Thon, J. Litzman,
- 520 9_
- $a The neonatal Fc receptor (FcRn) acts as a key regulator of IgG homeostasis and is an important sensor of luminal infection. We analyzed the influence of FcRn expression on disease phenotype and the catabolism of therapeutically administered intravenous immunoglobulins (IVIG) in 28 patients with common variable immunodeficiency (CVID). Patients with generalized bronchiectasis and fibrosis had lower levels of FCRN mRNA compared to patients without these complications (P=0.027 and P=0.041, respectively). Moreover, FCRN mRNA levels correlated negatively with the extent of bronchiectasis and the rate of IgG decline after infusion of IVIG (P=0.027 and P=0.045, respectively). No relationship of FCRN expression with age at disease onset, age at diagnosis, diagnostic delay, IgG levels or frequency of infections before or during replacement immunoglobulin treatment, the presence of lung functional abnormalities, chronic diarrhea, granulomas, lymphadenopathy, splenomegaly or autoimmune phenomena was observed. Our results showed that FcRn might play a role in the development of lung structural abnormalities and in the catabolism of IVIG in patients with CVID.
- 650 _2
- $a mladiství $7 D000293
- 650 _2
- $a dospělí $7 D000328
- 650 _2
- $a senioři $7 D000368
- 650 _2
- $a běžná variabilní imunodeficience $x genetika $x imunologie $x patologie $x patofyziologie $7 D017074
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a exprese genu $7 D015870
- 650 _2
- $a MHC antigeny I. třídy $x genetika $7 D015395
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a imunoglobulin G $x krev $7 D007074
- 650 _2
- $a intravenózní imunoglobuliny $x krev $7 D016756
- 650 _2
- $a plíce $x imunologie $x patologie $x patofyziologie $7 D008168
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a lidé středního věku $7 D008875
- 650 _2
- $a minisatelitní repetice $7 D018598
- 650 _2
- $a fenotyp $7 D010641
- 650 _2
- $a promotorové oblasti (genetika) $7 D011401
- 650 _2
- $a messenger RNA $x genetika $x metabolismus $7 D012333
- 650 _2
- $a receptory Fc $x genetika $7 D011961
- 650 _2
- $a mladý dospělý $7 D055815
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Grodecká, Lucie $7 xx0142571
- 700 1_
- $a Ravčuková, Barbora $7 xx0105242
- 700 1_
- $a Kurecová, B
- 700 1_
- $a Postránecká, V
- 700 1_
- $a Vlcek, J
- 700 1_
- $a Jarkovský, Jiří $7 stk2008461294
- 700 1_
- $a Thon, Vojtěch $7 xx0060109
- 700 1_
- $a Litzman, Jiří, $7 xx0000488 $d 1958-
- 773 0_
- $w MED00005218 $t Clinical immunology (Orlando, Fla.) $x 1521-7035 $g Roč. 136, č. 3 (2010), s. 419-25
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/20627700 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y m
- 990 __
- $a 20120817 $b ABA008
- 991 __
- $a 20130508102851 $b ABA008
- 999 __
- $a ok $b bmc $g 947660 $s 782964
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2010 $b 136 $c 3 $d 419-25 $i 1521-7035 $m Clinical immunology $n Clin Immunol $x MED00005218
- GRA __
- $a NR9192 $p MZ0
- LZP __
- $a Pubmed-20120817/10/03